ArticleJournal of clinical medicine2026

Serum Transthyretin as a Prognostic and Therapeutic Biomarker in Transthyretin Amyloid Cardiomyopathy Patients Treated with Tafamidis.

Jacopo Costantino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.